Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Mayer-Pickel, K; Kolovetsiou-Kreiner, V; Stern, C; Münzker, J; Eberhard, K; Trajanoski, S; Lakovschek, IC; Ulrich, D; Csapo, B; Lang, U; Obermayer-Pietsch, B; Cervar-Zivkovic, M.
Effect of Low-Dose Aspirin on Soluble FMS-Like Tyrosine Kinase 1/Placental Growth Factor (sFlt-1/PlGF Ratio) in Pregnancies at High Risk for the Development of Preeclampsia.
J Clin Med. 2019; 8(9): Doi: 10.3390/jcm8091429 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Leading authors Med Uni Graz
Mayer-Pickel Karoline Ilse
Co-authors Med Uni Graz
Cervar-Zivkovic Mila
Csapo Bence Daniel
Eberhard Katharina
Gold ehem Ulrich Daniela
Kolovetsiou-Kreiner Vassiliki
Lakovschek Ioana-Claudia
Lang Uwe
Münzker Julia
Obermayer-Pietsch Barbara
Stern Christina
Trajanoski Slave
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Soluble FMS-like Tyrosine Kinase 1 (sFlt-1) and placental growth factor (PlGF) have been reported to be highly predictive several weeks before the onset of preeclampsia. To investigate longitudinal changes of serum levels sFlt-1 and PlGF in pregnant women at high risk for the development of preeclampsia and to reveal an impact of aspirin on maternal serum concentrations of sFlt-1 and PlGF. This was a prospective longitudinal study in 394 women with various risk factors for the development of preeclampsia (chronic hypertension, antiphospholipid syndrome/APS or systemic lupus erythematosus/SLE, thrombophilia, women with a history of preeclampsia, pathologic first trimester screening for preeclampsia) and 68 healthy women. Serum levels of sFlt-1 and PlGF were measured prospectively at 4-week intervals (from gestational weeks 12 until postpartum). The sFlt-1/PlGF ratio was significantly higher in women with an adverse obstetric outcome compared to women with a normal pregnancy, starting between 20 and 24 weeks of gestation. There was no effect of aspirin on sFlt-1/PlGF ratio in women with chronic hypertension, APS/SLE, thrombophilia and controls. The use of aspirin showed a trend towards an improvement of the sFlt-1/PlGF ratio in women with preeclampsia in a previous pregnancy and a significant effect on the sFlt-1/PlGF ratio in women with a pathologic first trimester screening for preeclampsia. Our findings reveal an impact of aspirin on sFlt-1/PlGF ratio in women with a pathologic first trimester screening for preeclampsia, strongly supporting its prophylactic use.

Find related publications in this database (Keywords)
adverse pregnancy outcome
aspirin
first trimester screening for preeclampsia
high-risk pregnancies
preeclampsia
sFlt1/PlGF ratio
© Med Uni GrazImprint